找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Current Controversies in Bone Marrow Transplantation; Brian J. Bolwell (Director, Staff Physician) Book 2000 Humana Press Inc. 2000 blood.

[復(fù)制鏈接]
樓主: Limbic-System
31#
發(fā)表于 2025-3-27 00:55:36 | 只看該作者
Carmen Colitz,Fabiano Montiani-Ferreiraute leukemia induced complete remission (CR) in the majority of patients, but postremission therapy was inadequate to prevent relapse .. Relapsed patients, and those who failed to achieve CR, invariably died from their leukemia.
32#
發(fā)表于 2025-3-27 03:36:56 | 只看該作者
33#
發(fā)表于 2025-3-27 05:58:34 | 只看該作者
Additional Psychocultural ThemesGenerally, eligibility includes patients less than 55, 60, or 65 yr of age. Many autologous BMT (ABMT) protocols also have age cutoffs restricting patient eligibility. The reason for such an age cutoff is presumably that the transplant procedure itself is prohibitively risky in older patients. Commo
34#
發(fā)表于 2025-3-27 09:47:34 | 只看該作者
Additional Psychocultural Themesowever, this approach has been limited by the availability of suitable human leukocyte antigen (HLA)-matched related donors, and by the occurrence of severe graft-vs-host disease (GVHD) when bone marrow (BM) from HLA-matched unrelated donor (MUD), or partially HLA-mismatched family member grafts, ar
35#
發(fā)表于 2025-3-27 14:36:26 | 只看該作者
36#
發(fā)表于 2025-3-27 20:42:40 | 只看該作者
Jong-Hwa Chun,Jang-Jun Bahk,In-Kwon Umengraftment unless the donor is syngeneic or the recipient is profoundly immunoincompetent. When BMT is performed for malignant disease, treatment of the recipient to permit engraftment is also used to eliminate residual malignancy. The ultimate success of allo-BMT for leukemia clearly depends upon
37#
發(fā)表于 2025-3-28 01:32:42 | 只看該作者
Martin Torvald Hovland,Srikumar Royd to CML is 1.5/ 100,000/yr .. CML is characterized by a specific chromosomal abnormality referred to as the Philadelphia chromosome (Ph.) .,.. The Ph. results from the reciprocal translocation of the . proto-oncogene on the long arm of chromosome 9 (g34.1) to the 5.8 kb breakpoint cluster region (b
38#
發(fā)表于 2025-3-28 03:45:14 | 只看該作者
39#
發(fā)表于 2025-3-28 10:01:44 | 只看該作者
40#
發(fā)表于 2025-3-28 11:48:21 | 只看該作者
Heritability of Aggressive Behavior,of the eradication of leukemia by high-dose chemotherapy (CT), stem cells previously collected, either in remission or at time of active disease, will almost certainly be contaminated by a population of tumor cells. Viable cells will logically result in relapse. If, however, there are no viable tumo
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 11:18
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
弥渡县| 富川| 潜山县| 金溪县| 尼玛县| 闽侯县| 广宁县| 屯昌县| 黄冈市| 建昌县| 金华市| 枣强县| 和田县| 凭祥市| 桐庐县| 循化| 阿尔山市| 资中县| 旺苍县| 陈巴尔虎旗| 大邑县| 阿荣旗| 剑川县| 黄陵县| 若尔盖县| 定远县| 罗源县| 信丰县| 宜黄县| 封丘县| 鹿邑县| 昆山市| 华亭县| 无棣县| 赣州市| 界首市| 高邑县| 安图县| 井研县| 桃园市| 沂南县|